Free Trial

Bowhead Specialty (NYSE:BOW) Announces Earnings Results

Bowhead Specialty logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • Bowhead topped estimates with EPS $0.48 vs. $0.42, reported GWP up 24% to ~$217M and adjusted net income rising ~40%, delivering a combined ratio of 95.3%, signaling strong top- and bottom-line improvement.
  • Digital underwriting is scaling: Baleen produced $11.4M in Q1 (3x year‑ago) and Express >$3M, with digital platforms now ~7% of GWP and showing fast quote/bind metrics.
  • Management flagged reserve uncertainty—IBNR ~91% of total reserves with $0.6M of prior‑accident‑year timing adjustments—and increased quota share to 33.5% while raising $150M of debt/credit capacity, which supports capital but will lower net written premium.
  • Interested in Bowhead Specialty? Here are five stocks we like better.

Bowhead Specialty (NYSE:BOW - Get Free Report) posted its quarterly earnings data on Tuesday. The company reported $0.48 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.42 by $0.06, FiscalAI reports. Bowhead Specialty had a net margin of 9.75% and a return on equity of 13.27%.

Here are the key takeaways from Bowhead Specialty's conference call:

  • Bowhead reported strong top- and bottom-line results with GWP up 24% to ~$217M and adjusted net income rising ~40% (diluted adjusted EPS $0.48), producing a combined ratio of 95.3%.
  • Digital underwriting is gaining traction: Baleen generated $11.4M in Q1 (3x year‑ago), Express produced >$3M, and the platforms delivered fast quote/bind metrics and are ~7% of GWP with clear scaling plans.
  • Reserve disclosure shows reliance on industry data and a high IBNR profile (IBNR is ~91% of total reserves), plus $0.6M of prior‑accident‑year IBNR timing adjustments, indicating reserve uncertainty for long‑tail lines.
  • May 1 reinsurance renewals increased the quota share to 33.5% (and reduced XL retention), and Bowhead expanded its American Family agreement and has $150M of debt proceeds plus a credit facility, which supports capital but will lower net written premium.
  • Operating leverage is improving: operating expense ratio declined ~2.9 points, pre‑tax investment income rose ~44% to $18M (book yield 4.6%), and management expects expense ratio to remain below the low‑30s range going forward.

Bowhead Specialty Stock Performance

NYSE BOW traded up $1.65 during trading hours on Tuesday, reaching $24.93. The company's stock had a trading volume of 60,482 shares, compared to its average volume of 205,486. The stock has a market cap of $818.83 million, a PE ratio of 15.56, a PEG ratio of 0.74 and a beta of -0.15. The business has a 50-day simple moving average of $23.52 and a 200 day simple moving average of $25.17. Bowhead Specialty has a 52 week low of $21.21 and a 52 week high of $41.61. The company has a current ratio of 0.52, a quick ratio of 0.52 and a debt-to-equity ratio of 0.33.

Hedge Funds Weigh In On Bowhead Specialty

Several hedge funds and other institutional investors have recently modified their holdings of BOW. California State Teachers Retirement System lifted its position in Bowhead Specialty by 28.4% in the 3rd quarter. California State Teachers Retirement System now owns 15,713 shares of the company's stock valued at $425,000 after purchasing an additional 3,477 shares during the last quarter. Invesco Ltd. raised its holdings in shares of Bowhead Specialty by 3.5% during the fourth quarter. Invesco Ltd. now owns 14,484 shares of the company's stock valued at $413,000 after buying an additional 490 shares during the last quarter. Graham Capital Management L.P. boosted its position in shares of Bowhead Specialty by 14.0% during the fourth quarter. Graham Capital Management L.P. now owns 14,400 shares of the company's stock worth $411,000 after buying an additional 1,770 shares during the period. Jump Financial LLC boosted its position in shares of Bowhead Specialty by 6.6% during the fourth quarter. Jump Financial LLC now owns 10,860 shares of the company's stock worth $310,000 after buying an additional 673 shares during the period. Finally, Orion Porfolio Solutions LLC bought a new position in Bowhead Specialty in the 4th quarter worth approximately $282,000.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on BOW. Royal Bank Of Canada lowered their target price on Bowhead Specialty from $33.00 to $30.00 and set an "outperform" rating for the company in a research note on Wednesday, February 25th. Citizens Jmp dropped their price target on shares of Bowhead Specialty from $38.00 to $35.00 and set a "market outperform" rating for the company in a research note on Monday, April 13th. Morgan Stanley cut their target price on shares of Bowhead Specialty from $27.00 to $25.00 and set an "equal weight" rating on the stock in a research note on Monday, April 6th. Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Bowhead Specialty in a research report on Friday, March 27th. Finally, Zacks Research raised Bowhead Specialty from a "strong sell" rating to a "hold" rating in a report on Tuesday, February 24th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and four have given a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $31.83.

View Our Latest Report on Bowhead Specialty

About Bowhead Specialty

(Get Free Report)

Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.

See Also

Earnings History for Bowhead Specialty (NYSE:BOW)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Bowhead Specialty Right Now?

Before you consider Bowhead Specialty, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bowhead Specialty wasn't on the list.

While Bowhead Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines